Variant report

Variant	nsv553757
Chromosome Location	chr11:23564329-23896729
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:23808741-23808892	HepG2	liver:	n/a	n/a
2	ATF1	chr11:23619441-23619564	K562	blood:	n/a	n/a
3	BACH1	chr11:23878232-23878445	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr11:23666004-23666814	H1-hESC	embryonic stem cell:	n/a	chr11:23666599-23666613
5	BRCA1	chr11:23895497-23895518	H1-hESC	embryonic stem cell:	n/a	n/a
6	BRCA1	chr11:23791141-23791164	Hela-S3	cervix:	n/a	n/a
7	CEBPB	chr11:23878241-23878611	A549	lung:	n/a	chr11:23878381-23878392
8	CEBPB	chr11:23878304-23878551	ECC-1	luminal epithelium:	n/a	chr11:23878381-23878392
9	CEBPB	chr11:23876059-23876251	IMR90	lung:	n/a	n/a
10	CEBPB	chr11:23633294-23633626	IMR90	lung:	n/a	chr11:23633463-23633474
11	CEBPB	chr11:23891315-23891609	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr11:23883263-23883345	H1-hESC	embryonic stem cell:	n/a	chr11:23883330-23883341 chr11:23883331-23883340 chr11:23883331-23883340 chr11:23883331-23883340 chr11:23883329-23883340 chr11:23883331-23883340
13	CEBPB	chr11:23679204-23679446	A549	lung:	n/a	n/a
14	CEBPB	chr11:23605889-23606089	HepG2	liver:	n/a	chr11:23605949-23605960 chr11:23605951-23605962 chr11:23605949-23605962
15	CEBPB	chr11:23878214-23878526	MCF-7	breast:	n/a	chr11:23878381-23878392
16	CEBPB	chr11:23883188-23883494	HepG2	liver:	n/a	chr11:23883330-23883341 chr11:23883331-23883340 chr11:23883331-23883340 chr11:23883331-23883340 chr11:23883329-23883340 chr11:23883331-23883340
17	CEBPB	chr11:23829075-23829384	HepG2	liver:	n/a	chr11:23829233-23829244
18	CEBPB	chr11:23718277-23718657	A549	lung:	n/a	chr11:23718462-23718475 chr11:23718464-23718473 chr11:23718464-23718473 chr11:23718462-23718475 chr11:23718464-23718473 chr11:23718464-23718473 chr11:23718464-23718475 chr11:23718462-23718473
19	CEBPB	chr11:23878204-23878582	Hela-S3	cervix:	n/a	chr11:23878381-23878392
20	CEBPB	chr11:23891235-23891626	Hela-S3	cervix:	n/a	n/a
21	CEBPB	chr11:23878236-23878516	MCF-7	breast:	n/a	chr11:23878381-23878392
22	CEBPB	chr11:23718289-23718634	HepG2	liver:	n/a	chr11:23718462-23718475 chr11:23718464-23718473 chr11:23718464-23718473 chr11:23718462-23718475 chr11:23718464-23718473 chr11:23718464-23718473 chr11:23718464-23718475 chr11:23718462-23718473
23	CEBPB	chr11:23820772-23821109	A549	lung:	n/a	n/a
24	CEBPB	chr11:23718286-23718630	H1-hESC	embryonic stem cell:	n/a	chr11:23718462-23718475 chr11:23718464-23718473 chr11:23718464-23718473 chr11:23718462-23718475 chr11:23718464-23718473 chr11:23718464-23718473 chr11:23718464-23718475 chr11:23718462-23718473
25	CEBPB	chr11:23844250-23844479	IMR90	lung:	n/a	chr11:23844394-23844405
26	CEBPB	chr11:23883174-23883477	IMR90	lung:	n/a	chr11:23883330-23883341 chr11:23883331-23883340 chr11:23883331-23883340 chr11:23883331-23883340 chr11:23883329-23883340 chr11:23883331-23883340
27	CEBPB	chr11:23891244-23891591	HepG2	liver:	n/a	n/a
28	CEBPB	chr11:23887287-23887522	MCF-7	breast:	n/a	n/a
29	CEBPB	chr11:23777380-23777595	HepG2	liver:	n/a	n/a
30	CEBPB	chr11:23718286-23718649	IMR90	lung:	n/a	chr11:23718462-23718475 chr11:23718464-23718473 chr11:23718464-23718473 chr11:23718462-23718475 chr11:23718464-23718473 chr11:23718464-23718473 chr11:23718464-23718475 chr11:23718462-23718473
31	CEBPB	chr11:23829111-23829319	K562	blood:	n/a	chr11:23829233-23829244
32	CEBPB	chr11:23829064-23829390	IMR90	lung:	n/a	chr11:23829233-23829244
33	CEBPB	chr11:23878231-23878550	A549	lung:	n/a	chr11:23878381-23878392
34	CEBPB	chr11:23626580-23626913	IMR90	lung:	n/a	chr11:23626756-23626769 chr11:23626758-23626769
35	CEBPB	chr11:23723649-23723934	HepG2	liver:	n/a	n/a
36	CEBPB	chr11:23633313-23633621	HepG2	liver:	n/a	chr11:23633463-23633474
37	CEBPB	chr11:23747309-23747636	Hela-S3	cervix:	n/a	n/a
38	CEBPB	chr11:23718315-23718599	K562	blood:	n/a	chr11:23718462-23718475 chr11:23718464-23718473 chr11:23718464-23718473 chr11:23718462-23718475 chr11:23718464-23718473 chr11:23718464-23718473 chr11:23718464-23718475 chr11:23718462-23718473
39	CEBPB	chr11:23808790-23808947	HepG2	liver:	n/a	chr11:23808906-23808917
40	CEBPB	chr11:23633311-23633632	A549	lung:	n/a	chr11:23633463-23633474
41	CEBPB	chr11:23820766-23821130	IMR90	lung:	n/a	chr11:23821104-23821117
42	CEBPB	chr11:23878225-23878534	HepG2	liver:	n/a	chr11:23878381-23878392
43	CEBPB	chr11:23887264-23887584	MCF-7	breast:	n/a	n/a
44	CEBPB	chr11:23749404-23749739	Hela-S3	cervix:	n/a	n/a
45	CEBPB	chr11:23723663-23723849	H1-hESC	embryonic stem cell:	n/a	n/a
46	CEBPB	chr11:23820809-23821124	HepG2	liver:	n/a	chr11:23821104-23821117
47	CEBPB	chr11:23747390-23747532	A549	lung:	n/a	n/a
48	CEBPB	chr11:23844303-23844514	HepG2	liver:	n/a	chr11:23844394-23844405
49	CEBPB	chr11:23891258-23891626	A549	lung:	n/a	n/a
50	CEBPB	chr11:23878299-23878513	A549	lung:	n/a	chr11:23878381-23878392

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:23752469-23752519	MCF-7	breast:	n/a
2	chr11:23895772-23895822	HCM	heart:	n/a
3	chr11:23754485-23754535	HIPEpiC	eye:	n/a
4	chr11:23811425-23811475	ProgFib	skin:	n/a
5	chr11:23752138-23752188	HNPCEpiC	eye:	n/a
6	chr11:23752138-23752188	HRPEpiC	eye:	n/a
7	chr11:23752001-23752051	HMEC	breast:	n/a
8	chr11:23752138-23752188	PrEC	prostate:	n/a
9	chr11:23754485-23754535	AG04449	skin:	fetal
10	chr11:23895772-23895822	AG10803	skin:	n/a
11	chr11:23811425-23811475	MCF-7	breast:	n/a
12	chr11:23674834-23674884	HEEpiC	esophagus:	n/a
13	chr11:23674834-23674884	SAEC	small airway:	n/a
14	chr11:23752222-23752272	CMK	blood:	n/a
15	chr11:23752360-23752410	SK-N-SH	brain:	n/a
16	chr11:23811425-23811475	BJ	skin:	n/a
17	chr11:23751628-23751678	Hela-S3	cervix:	n/a
18	chr11:23674834-23674884	PFSK-1	brain:	n/a
19	chr11:23811425-23811475	K562	blood:	n/a
20	chr11:23752222-23752272	HCPEpiC	choroid plexus:	n/a
21	chr11:23895772-23895822	SAEC	small airway:	n/a
22	chr11:23752222-23752272	SAEC	small airway:	n/a
23	chr11:23754485-23754535	ECC-1	luminal epithelium:	n/a
24	chr11:23674100-23674150	SK-N-MC	brain:	n/a
25	chr11:23674100-23674150	Hepatocyte	liver:	n/a
26	chr11:23674834-23674884	HEK293	kidney:	embryo
27	chr11:23752001-23752051	HUVEC	blood vessel:	n/a
28	chr11:23895772-23895822	HEEpiC	esophagus:	n/a
29	chr11:23752222-23752272	HEEpiC	esophagus:	n/a
30	chr11:23752360-23752410	HPAEpiC	pulmonary alveolar:	n/a
31	chr11:23811425-23811475	AG04450	lung:	fetal
32	chr11:23752222-23752272	GM19239	blood:	n/a
33	chr11:23752360-23752410	PANC-1	pancreas:	n/a
34	chr11:23752360-23752410	NT2-D1	testis:	n/a
35	chr11:23674834-23674884	HCPEpiC	choroid plexus:	n/a
36	chr11:23811425-23811475	HPAEpiC	pulmonary alveolar:	n/a
37	chr11:23752469-23752519	NH-A	brain:	n/a
38	chr11:23752360-23752410	GM19239	blood:	n/a
39	chr11:23751628-23751678	IMR90	lung:	fetal
40	chr11:23752469-23752519	AG04449	skin:	fetal
41	chr11:23752222-23752272	AG09319	gingival:	n/a
42	chr11:23752469-23752519	U87	brain:	n/a
43	chr11:23752469-23752519	HL-60	blood:	n/a
44	chr11:23752222-23752272	NH-A	brain:	n/a
45	chr11:23752138-23752188	HAEpiC	amniotic membrane:	n/a
46	chr11:23751628-23751678	BE2_C	brain:	n/a
47	chr11:23754485-23754535	HCM	heart:	n/a
48	chr11:23674100-23674150	U87	brain:	n/a
49	chr11:23752222-23752272	Hepatocyte	liver:	n/a
50	chr11:23752222-23752272	ovcar-3	ovarian:	n/a

No.	Distal block	Cell Line	Cell type
1	chr11:23623560..23625973-chr11:23631898..23634252,2	MCF-7	breast:
2	chr11:23711821..23714725-chr11:23720399..23722381,2	K562	blood:
3	chr11:23646416..23648510-chr11:23648713..23651046,2	K562	blood:
4	chr11:23712261..23714812-chr11:23726962..23729358,2	K562	blood:
5	chr11:23745761..23746467-chr2:67682721..67683342,2	MCF-7	breast:
6	chr11:23135057..23135761-chr11:23575313..23576218,2	MCF-7	breast:
7	chr11:23713225..23715504-chr11:23720246..23721899,2	K562	blood:
8	chr11:23766902..23769192-chr6:80655556..80658439,2	MCF-7	breast:
9	chr11:23646416..23648510-chr11:23648713..23651046,2	K562	blood:
10	chr11:23711821..23714725-chr11:23720399..23722381,2	K562	blood:
11	chr11:23798376..23799116-chr5:32449587..32450235,2	MCF-7	breast:
12	chr11:23712261..23714812-chr11:23726962..23729358,2	K562	blood:
13	chr11:23713225..23715504-chr11:23720246..23721899,2	K562	blood:
14	chr11:23623560..23625973-chr11:23631898..23634252,2	MCF-7	breast:
15	chr11:23628052..23630839-chr11:23632616..23635323,2	K562	blood:
16	chr11:23822728..23824994-chr11:23830826..23833587,2	K562	blood:
17	chr11:23628052..23630839-chr11:23632616..23635323,2	K562	blood:
18	chr11:23822728..23824994-chr11:23830826..23833587,2	K562	blood:
19	chr11:23438196..23441046-chr11:23620959..23622715,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RP11-17A1.2.1-5	chr11:23818256-23819005	NONHSAT018430
2	lnc-LUZP2-1	chr11:23758946-23760526	NONHSAT018426
3	lnc-RP11-17A1.2.1-2	chr11:23826000-23826222	XLOC_009395
4	lnc-LUZP2-4	chr11:23697000-23697314	NONHSAT018425
5	lnc-LUZP2-1	chr11:23752134-23752432	ENSG00000255193
6	lnc-RP11-17A1.2.1-2	chr11:23802334-23802418	ENSG00000254861
7	lnc-RP11-17A1.2.1-2	chr11:23782876-23783176	ENSG00000254861
8	lnc-LUZP2-5	chr11:23683281-23683759	NONHSAT018424
9	lnc-LUZP2-1	chr11:23753146-23753204	ENSG00000255193
10	lnc-LUZP2-1	chr11:23816369-23816430	ENSG00000255193
11	lnc-RP11-17A1.2.1-6	chr11:23874839-23875216	NONHSAT018433
12	lnc-RP11-17A1.2.1-2	chr11:23829736-23829778	XLOC_009395
13	lnc-LUZP2-5	chr11:23697639-23701053	NONHSAT018424
14	lnc-LUZP2-1	chr11:23751855-23752432	NONHSAT018426
15	lnc-LUZP2-1	chr11:23756818-23757022	NONHSAT018426
16	lnc-LUZP2-1	chr11:23818254-23818516	ENSG00000255193
17	lnc-RP11-17A1.2.1-2	chr11:23782899-23783176	XLOC_009394
18	lnc-RP11-17A1.2.1-5	chr11:23817463-23817487	NONHSAT018430
19	lnc-RP11-17A1.2.1-2	chr11:23789323-23789362	XLOC_009394
20	lnc-RP11-17A1.2.1-6	chr11:23877391-23877541	NONHSAT018433
21	lnc-LUZP2-1	chr11:23753146-23753224	NONHSAT018426
22	lnc-LUZP2-4	chr11:23695358-23696510	NONHSAT018425
23	lnc-RP11-17A1.2.1-2	chr11:23826025-23826144	ENSG00000254861

Variant related genes	Relation type
ENSG00000255193	TF binding region
RNU6-783P	TF binding region
ENSG00000254861	TF binding region
ENSG00000255193	CpG island
RNU6-783P	CpG island
ENSG00000254861	CpG island
ENSG00000118402	chromatin interactions

Extended variants
information (count: 7209 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:7209 , 50 per page) page: 1 2 3 4 5 6 7 ... 145

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7122954	chr11:23564329-23564330	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs190006102	chr11:23564331-23564332	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs575246613	chr11:23564337-23564338	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs1564097	chr11:23564431-23564432	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
5	rs551045016	chr11:23564457-23564458	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs372861394	chr11:23564480-23564481	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs7122789	chr11:23564493-23564494	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs540233984	chr11:23564519-23564520	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs147655192	chr11:23564525-23564526	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs118124627	chr11:23564536-23564537	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs552396896	chr11:23564555-23564556	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs574071246	chr11:23564562-23564563	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs562731084	chr11:23564571-23564572	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs530892894	chr11:23564596-23564597	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs551019777	chr11:23564601-23564602	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs567676969	chr11:23564606-23564607	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs536199890	chr11:23564636-23564637	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs180803613	chr11:23564648-23564649	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs184586764	chr11:23564664-23564665	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs538995282	chr11:23564717-23564718	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs558864894	chr11:23564754-23564755	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs569471734	chr11:23564761-23564762	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs10834130	chr11:23564787-23564788	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs189349203	chr11:23564816-23564817	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs11027304	chr11:23564828-23564829	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs111658684	chr11:23564839-23564840	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs11027305	chr11:23564843-23564844	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
28	rs577187202	chr11:23564874-23564875	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs139695526	chr11:23564907-23564908	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs562656434	chr11:23564921-23564922	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs531506370	chr11:23564922-23564923	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs541663531	chr11:23564933-23564934	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs374673710	chr11:23565056-23565057	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs561393963	chr11:23565076-23565077	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs530175385	chr11:23565085-23565086	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs114104400	chr11:23565098-23565099	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs114761031	chr11:23565110-23565111	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs532654254	chr11:23565111-23565112	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs552804518	chr11:23565118-23565119	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs571359771	chr11:23565133-23565134	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs181973746	chr11:23565166-23565167	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs376626802	chr11:23565209-23565210	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs543297389	chr11:23565211-23565212	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs185939104	chr11:23565237-23565238	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs76936943	chr11:23565259-23565260	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs372616975	chr11:23565328-23565329	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs80199539	chr11:23565386-23565387	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs12796509	chr11:23565493-23565494	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs145772040	chr11:23565548-23565549	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs12420082	chr11:23565554-23565555	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance

Variant related diseases (count:58)

Disease	PMID	Source
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Multiple myeloma	16461302	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Medulloblastoma	16783165	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Congenital diaphragmatic hernia	21525063	CNVD
Renal cell carcinoma	18194544	CNVD
Myelofibrosis	22110671	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
Chordoma	18071362	CNVD
Autism	22102821	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21364760	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Renal cell carcinoma	21215367	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD

Chromatin state (count:382 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:23561600-23577600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr11:23561800-23565400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
3	chr11:23562600-23564800	Enhancers	Dnd41	blood
4	chr11:23563000-23565400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr11:23563400-23565400	Weak transcription	HUES48 Cell Line	embryonic stem cell
6	chr11:23564000-23564400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr11:23564000-23564600	Enhancers	Fetal Intestine Large	intestine
8	chr11:23564000-23564600	Enhancers	Fetal Intestine Small	intestine
9	chr11:23564000-23565400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
10	chr11:23564000-23565400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
11	chr11:23564000-23565600	Enhancers	HUVEC	blood vessel
12	chr11:23564200-23565200	Weak transcription	HUES64 Cell Line	embryonic stem cell
13	chr11:23564400-23565400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr11:23564800-23565400	Weak transcription	Dnd41	blood
15	chr11:23565200-23566000	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr11:23565400-23565600	Enhancers	iPS-20b Cell Line	embryonic stem cell
17	chr11:23565400-23565800	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr11:23565400-23565800	Enhancers	HUES48 Cell Line	embryonic stem cell
19	chr11:23565400-23565800	Enhancers	iPS-15b Cell Line	embryonic stem cell
20	chr11:23565400-23565800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
21	chr11:23565400-23565800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
22	chr11:23565400-23565800	Enhancers	Dnd41	blood
23	chr11:23565800-23566000	Weak transcription	Dnd41	blood
24	chr11:23565800-23568600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr11:23566000-23566600	Enhancers	Dnd41	blood
26	chr11:23571600-23572000	Enhancers	Dnd41	blood
27	chr11:23571800-23572400	Active TSS	Primary T helper memory cells from peripheral blood 2	blood
28	chr11:23575600-23577600	Enhancers	HUVEC	blood vessel
29	chr11:23576200-23576800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
30	chr11:23576400-23577400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
31	chr11:23576800-23577400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr11:23576800-23577600	Enhancers	Hela-S3	cervix
33	chr11:23577000-23577600	Enhancers	NH-A	brain
34	chr11:23577200-23578400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
35	chr11:23577200-23578400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
36	chr11:23577200-23578600	Enhancers	Dnd41	blood
37	chr11:23577600-23578400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
38	chr11:23577600-23579800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
39	chr11:23578000-23578400	Enhancers	HUES6 Cell Line	embryonic stem cell
40	chr11:23579800-23580400	Enhancers	ES-I3 Cell Line	embryonic stem cell
41	chr11:23580000-23580600	Enhancers	HUES48 Cell Line	embryonic stem cell
42	chr11:23580200-23580600	Enhancers	HUES64 Cell Line	embryonic stem cell
43	chr11:23585400-23587000	Enhancers	Dnd41	blood
44	chr11:23585600-23587800	Enhancers	Brain Germinal Matrix	brain
45	chr11:23585800-23586200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
46	chr11:23586600-23587000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
47	chr11:23587000-23588400	Weak transcription	Dnd41	blood
48	chr11:23587000-23591200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
49	chr11:23588400-23593400	Enhancers	Dnd41	blood
50	chr11:23590600-23591400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links